MPWT
EW icon

MassMutual Private Wealth & Trust’s Edwards Lifesciences EW Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
1,833
+4
+0.2% +$335 ﹤0.01% 478
2026
Q1 		$146K Sell
1,829
-60
-3% -$4.95K ﹤0.01% 495
2025
Q4 		$161K Buy
1,889
+31
+2% +$2.54K ﹤0.01% 486
2025
Q3 		$144K Buy
1,858
+120
+7% +$9.38K ﹤0.01% 502
2025
Q2 		$136K Sell
1,738
-19,921
-92% -$1.49M ﹤0.01% 517
2025
Q1 		$1.57M Buy
21,659
+583
+3% +$41.7K 0.05% 219
2024
Q4 		$1.56M Buy
21,076
+256
+1% +$17.9K 0.04% 220
2024
Q3 		$1.37M Sell
20,820
-533
-2% -$38.7K 0.04% 219
2024
Q2 		$1.97M Buy
21,353
+261
+1% +$23.1K 0.06% 193
2024
Q1 		$2.02M Sell
21,092
-593
-3% -$49.8K 0.06% 185
2023
Q4 		$1.65M Sell
21,685
-1,951
-8% -$136K 0.06% 200
2023
Q3 		$1.64M Sell
23,636
-467
-2% -$37.5K 0.06% 197
2023
Q2 		$2.27M Sell
24,103
-94
-0.4% -$8.17K 0.08% 183
2023
Q1 		$2M Buy
24,197
+201
+0.8% +$15.8K 0.08% 187
2022
Q4 		$1.79M Buy
23,996
+17
+0.1% +$1.31K 0.07% 190
2022
Q3 		$1.98M Buy
23,979
+274
+1% +$26.4K 0.09% 178
2022
Q2 		$2.25M Buy
23,705
+23,067
+3,616% +$2.39M 0.1% 171
2022
Q1 		$75K Buy
638
+130
+26% +$14.6K ﹤0.01% 422
2021
Q4 		$66K Sell
508
-65
-11% -$7.58K ﹤0.01% 455
2021
Q3 		$65K Sell
573
-36
-6% -$4.11K ﹤0.01% 447
2021
Q2 		$63K Buy
609
+443
+267% +$41.8K ﹤0.01% 449
2021
Q1 		$14K Buy
166
+151
+1,007% +$12.8K ﹤0.01% 561
2020
Q4 		$1K Hold
15
– – ﹤0.01% 835
2020
Q3 		$1K Hold
15
– – ﹤0.01% 705
2020
Q2 		$1K Sell
15
-42
-74% -$2.98K ﹤0.01% 685
2020
Q1 		$4K Sell
57
-6,267
-99% -$452K ﹤0.01% 590
2019
Q4 		$492K Hold
6,324
– – 0.03% 274
2019
Q3 		$464K Buy
6,324
+4,857
+331% +$341K 0.03% 272
2019
Q2 		$90K Buy
1,467
+1,200
+449% +$72.6K 0.01% 387
2019
Q1 		$17K Buy
267
+159
+147% +$9.07K ﹤0.01% 527
2018
Q4 		$5.51K Hold
108
– – ﹤0.01% 649
2018
Q3 		$6.27K Sell
108
-168
-61% -$8.22K ﹤0.01% 677
2018
Q2 		$13.4K Sell
276
-582
-68% -$27.2K ﹤0.01% 564
2018
Q1 		$39.9K Sell
858
-2,112
-71% -$91.7K ﹤0.01% 433
2017
Q4 		$112K Sell
2,970
-38,844
-93% -$1.43M 0.01% 387
2017
Q3 		$1.52M Sell
41,814
-2,496
-6% -$95.2K 0.13% 150
2017
Q2 		$1.75M Sell
44,310
-3,522
-7% -$129K 0.16% 147
2017
Q1 		$1.5M Buy
47,832
+11,913
+33% +$373K 0.14% 153
2016
Q4 		$1.12M Buy
+35,919
New +$1.16M 0.14% 147
2016
Q2 		$20.8K Sell
627
-65,415
-99% -$2.24M ﹤0.01% 455
2016
Q1 		$1.94M Sell
66,042
-35,019
-35% -$966K 0.26% 109
2015
Q4 		$2.66M Buy
101,061
+100,521
+18,615% +$2.61M 0.38% 70
2015
Q3 		$9.19K Buy
+540
New +$13K ﹤0.01% 537
2015
Q2 		– Sell
-240
Closed -$5.7K – 762
2015
Q1 		$5.7K Sell
240
-540
-69% -$12.1K ﹤0.01% 580
2014
Q4 		$16.6K Buy
780
+240
+44% +$4.82K 0.01% 354
2014
Q3 		$9.19K Buy
+540
New +$8.52K ﹤0.01% 528

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's EW Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Edwards Lifesciences (EW) stake by 0.22% in Q2 2026, buying an estimated $335 and bringing the position to 1,833 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

MassMutual Private Wealth & Trust first reported a position in EW in Q3 2014 and has held it in 46 quarters since. The position peaked at $2.66M in Q4 2015. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MassMutual Private Wealth & Trust held 1,833 shares of Edwards Lifesciences worth $166K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 4 Edwards Lifesciences shares in Q2 2026, an estimated $335.
  • Edwards Lifesciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #478 holding.
  • MassMutual Private Wealth & Trust first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 46 quarters since.
  • MassMutual Private Wealth & Trust's Edwards Lifesciences position peaked at $2.66M in Q4 2015.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.